The lockdown effects on a pediatric obese population in the COVID-19 era

M Valenzise1, F D'Amico2, U Cucinotta2

  • 1Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy. mvalenzise@unime.it.

Insights

The COVID-19 lockdown negatively impacted lifestyle behaviors in obese children, increasing sedentary activity and meal frequency. Parental education level correlated with dietary changes, highlighting potential long-term health risks.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Behavioral Science

Background:

  • The COVID-19 pandemic induced significant lifestyle changes, particularly affecting pediatric populations.
  • Overweight and obese children faced greater challenges due to increased sedentary behavior, poor diet, and social distancing during home confinement.
  • These factors hindered weight management efforts in at-risk children.

Purpose of the Study:

  • To analyze the impact of the COVID-19 lockdown on behavioral changes in obese and overweight children.
  • To explore the correlation between new lifestyle habits and parental educational attainment.
  • To assess changes in weight, BMI, and biochemical parameters pre- and post-lockdown.

Main Methods:

  • The study included 40 overweight and obese pediatric patients from Messina, Italy.
  • Evaluated weight, BMI, and biochemical markers (cholesterol, triglycerides, glucose, insulin, transaminases).
  • Assessed changes in diet, physical activity, and sedentary behavior post-lockdown, correlating with parental education levels.

Main Results:

  • A significant increase in daily meals was observed during lockdown (5 vs 3.2, P < 0.001).
  • Children with parents having a primary school diploma consumed more meals than those with secondary school diplomas (P=0.0019).
  • 95% of patients engaged in low physical activity, and 97.5% increased sedentary time; BMI increased, but biochemical parameters showed no significant pre- to post-lockdown correlation.

Conclusions:

  • The COVID-19 lockdown adversely affected healthy lifestyle maintenance in overweight and obese children.
  • While immediate biochemical markers were unaffected, long-term consequences remain a concern.
  • Sustained high sedentary activity and meal frequency may lead to future metabolic complications.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
718
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
21
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
17
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
25
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
34
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
28